Agenus (AGEN) Depreciation & Amortization (CF) (2010 - 2026)
Agenus' (AGEN) quarterly Depreciation & Amortization (CF) came in at $583000.0 in Q1 2026, down 81.8% year-on-year from $3.2 million in Q1 2025, and down 2.35% quarter-over-quarter from $597000.0 in Q4 2025.
Agenus (AGEN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Agenus' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $583000.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 81.8% year-over-year to $583000.0 in Q1 2026; TTM through Mar 2026 was $7.4 million, a 43.98% decrease from a year earlier, with the FY2025 full-year figure at $10.0 million, down 25.06% from the prior year.
- Depreciation & Amortization (CF) eased to $583000.0 in Q1 2026 per AGEN's latest filing, from $597000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $5.2 million in Q4 2023 and bottomed at $583000.0 in Q1 2026.
- The 5-year median for Depreciation & Amortization (CF) is $3.0 million (2023), against an average of $2.6 million.
- Across the five-year window, Depreciation & Amortization (CF) jumped 175.33% in 2023 and slumped 81.8% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $1.9 million in 2022, then soared by 175.33% to $5.2 million in 2023, then slumped by 37.32% to $3.3 million in 2024, then plunged by 81.69% to $597000.0 in 2025, then dropped by 2.35% to $583000.0 in 2026.
- Per Business Quant, the three latest AGEN Depreciation & Amortization (CF) figures stand at $583000.0 (Q1 2026), $597000.0 (Q4 2025), and $3.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | 583,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 583,000.00 |
| Mar 31, 2026 | 583,000.00 |
| Dec 31, 2025 | 597,000.00 |
| Dec 31, 2025 | 597,000.00 |
| Sep 30, 2025 | 3.03 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Dec 31, 2024 | 3.26 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Sep 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Mar 31, 2024 | 3.37 Mn |
| Dec 31, 2023 | 5.20 Mn |
| Dec 31, 2023 | 5.20 Mn |